Literature DB >> 23435042

The clinical approach to the detection of lipodystrophy - an AACE consensus statement.

Yehuda Handelsman1, Elif A Oral, Zachary T Bloomgarden, Rebecca J Brown, Jean L Chan, Daniel Einhorn, Alan J Garber, Abhimanyu Garg, W Timothy Garvey, George Grunberger, Robert R Henry, Norman Lavin, Carmen D Tapiador, Christian Weyer.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23435042      PMCID： PMC4108221          DOI： 10.4158/endp.19.1.v767575m65p5mr06

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  31 in total

1.  Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.

Authors:  A Luedtke; M Boschmann; C Colpe; S Engeli; F Adams; A L Birkenfeld; S Haufe; G Rahn; F C Luft; H H-J Schmidt; J Jordan
Journal:  Horm Metab Res       Date:  2012-01-24       Impact factor: 2.936

Review 2.  Clinical review#: Lipodystrophies: genetic and acquired body fat disorders.

Authors:  Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

3.  Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy.

Authors:  Charles Bolan; Elif Arioglu Oral; Phillip Gorden; Simeon Taylor; Susan F Leitman
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

4.  Serum adiponectin and leptin levels in patients with lipodystrophies.

Authors:  Wasim A Haque; Iichiro Shimomura; Yuji Matsuzawa; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

5.  Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

Authors:  E Arioglu; J Duncan-Morin; N Sebring; K I Rother; N Gottlieb; J Lieberman; D Herion; D E Kleiner; J Reynolds; A Premkumar; A E Sumner; J Hoofnagle; M L Reitman; S I Taylor
Journal:  Ann Intern Med       Date:  2000-08-15       Impact factor: 25.391

6.  Leptin-replacement therapy for lipodystrophy.

Authors:  Elif Arioglu Oral; Vinaya Simha; Elaine Ruiz; Alexa Andewelt; Ahalya Premkumar; Peter Snell; Anthony J Wagner; Alex M DePaoli; Marc L Reitman; Simeon I Taylor; Phillip Gorden; Abhimanyu Garg
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

Review 7.  Lipodystrophies.

Authors:  A Garg
Journal:  Am J Med       Date:  2000-02       Impact factor: 4.965

Review 8.  Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.

Authors:  Anoop Misra; Abhimanyu Garg
Journal:  Medicine (Baltimore)       Date:  2003-03       Impact factor: 1.889

9.  Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.

Authors:  Anil K Agarwal; Vinaya Simha; Elif Arioglu Oral; Stephanie A Moran; Phillip Gorden; Stephen O'Rahilly; Zohra Zaidi; Figen Gurakan; Silva A Arslanian; Aharon Klar; Alyne Ricker; Neil H White; Lutz Bindl; Karen Herbst; Kurt Kennel; Shailesh B Patel; Lihadh Al-Gazali; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

10.  Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.

Authors:  L Van Maldergem; J Magré; T E Khallouf; T Gedde-Dahl; M Delépine; O Trygstad; E Seemanova; T Stephenson; C S Albott; F Bonnici; V R Panz; J L Medina; P Bogalho; F Huet; S Savasta; A Verloes; J J Robert; H Loret; M De Kerdanet; N Tubiana-Rufi; A Mégarbané; J Maassen; M Polak; D Lacombe; C R Kahn; E L Silveira; F H D'Abronzo; F Grigorescu; M Lathrop; J Capeau; S O'Rahilly
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318
View more
  35 in total

1.  Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.

Authors:  Nevin Ajluni; Rasimcan Meral; Adam H Neidert; Graham F Brady; Eric Buras; Barbara McKenna; Frank DiPaola; Thomas L Chenevert; Jeffrey F Horowitz; Colleen Buggs-Saxton; Amit R Rupani; Peedikayil E Thomas; Marwan K Tayeh; Jeffrey W Innis; M Bishr Omary; Hari Conjeevaram; Elif A Oral
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-27       Impact factor: 3.478

Review 2.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

Review 3.  Lipodystrophy syndromes.

Authors:  Pedro Herranz; Raul de Lucas; Luis Pérez-España; Matias Mayor
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

4.  Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.

Authors:  Marisela Noorhasan; Daniel R Drozd; Carl Grunfeld; Joseph O Merrill; Greer A Burkholder; Michael J Mugavero; James H Willig; Amanda L Willig; Karen L Cropsey; Kenneth H Mayer; Aaron Blashill; Matthew Mimiaga; Mary E McCaul; Heidi Hutton; Geetanjali Chander; William C Mathews; Sonia Napravnik; Joseph J Eron; Katerina Christopoulos; Rob J Fredericksen; Robin M Nance; Joseph Chris Delaney; Paul K Crane; Michael S Saag; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Res Hum Retroviruses       Date:  2017-02-16       Impact factor: 2.205

Review 5.  Congenital lipodystrophies and dyslipidemias.

Authors:  Xavier Prieur; Cedric Le May; Jocelyne Magré; Bertrand Cariou
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

6.  Can Polycystic Ovarian Syndrome be cured? Unfolding the Concept of Secondary Polycystic Ovarian Syndrome!

Authors:  Suvarna Satish Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2019-07-18

7.  Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

Authors:  Rebecca J Brown; Cristina Adelia Meehan; Elaine Cochran; Kristina I Rother; David E Kleiner; Mary Walter; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 8.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

9.  Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy.

Authors:  Konstanze Miehle; Michael Stumvoll; Mathias Fasshauer; Thomas Hierl
Journal:  Endocrine       Date:  2017-10-09       Impact factor: 3.633

10.  Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.

Authors:  Rebecca J Brown; Elif A Oral; Elaine Cochran; David Araújo-Vilar; David B Savage; Alison Long; Gregory Fine; Taylor Salinardi; Phillip Gorden
Journal:  Endocrine       Date:  2018-04-12       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.